Mobiderm® Standard Armsleeve is a mobilizing armsleeve aimed at managing mild to moderate lymphedema.
It includes patented Mobiderm® Technology5 which promotes subcutaneous drainage of edematous1 and indurated areas, by creating a pressure differential between the parts of the skin compressed by the foam blocks of Mobiderm® Technology and the surrounding areas, which helps drain away the excess lymph fluid and reduce swelling2.
It is intended for the treatment of lymphedema in maintenance phase for day at rest and night to maintain the volume reduction1.
Mobiderm® Standard Armsleeve is available in various sizes and lengths (normal and long) to ensure a comfortable fit4 for different arm circumferences.
1 Dhar - Safety and Efficacy of a Mobiderm Compression Bandage During Intensive Phase of Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Randomized Controlled Trial (2022 June 8)
2 Quéré - Prospective multicenter observational study of lymphedema therapy: POLIT study - Vascular Desease Journal – 2014 – Pages 4 and 5
3Compared to made-to-mesure device
4Easier and quicker to put on and take off than a bandage, it conforms to the shape of the limb for enhanced comfort.
5 Patent granted in: Austria, Belgium, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Portugal, Romania, Slovakia, Spain, Sweden, Switzerland, United Kingdom, USA. Information valid as of 01 November 2024 (for 12 months)
Patient profile
Adult
Chronic Condition
Pediatric patient
Breast cancer survivor
